Clopidogrel and Macular ischaemia - a phase IV clinical study of FDA data
Macular ischaemia is found among people who take Clopidogrel, especially for people who are male, 60+ old.
The phase IV clinical study analyzes which people take Clopidogrel and have Macular ischaemia. It is created by eHealthMe based on reports of 78,666 people who have side effects when taking Clopidogrel from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
78,666 people reported to have side effects when taking Clopidogrel.
Among them, 7 people (0.01%) have Macular ischaemia.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 79,598 Clopidogrel users for its effectiveness, alternative drugs and more.
What is Macular ischaemia?
Macular ischaemia (broken foveal capillary ring) is found to be associated with 173 drugs and 77 conditions by eHealthMe.
Number of Clopidogrel and Macular ischaemia reports submitted per year:
Gender of people who have Macular ischaemia when taking Clopidogrel *:
- female: 0.0 %
- male: 100 %
Age of people who have Macular ischaemia when taking Clopidogrel *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 16.67 %
- 60+: 83.33 %
Common drugs people take besides Clopidogrel *:
- Xarelto: 6 people, 85.71%
- Rivaroxaban: 6 people, 85.71%
- Acetylsalicylic Acid: 6 people, 85.71%
- Tekturna: 1 person, 14.29%
- Triesence: 1 person, 14.29%
- Ranitidine: 1 person, 14.29%
- Ranexa: 1 person, 14.29%
- Plavix: 1 person, 14.29%
- Novolog: 1 person, 14.29%
- Vigamox: 1 person, 14.29%
Common side effects people have besides Macular ischaemia *:
- Hemiparesis (weakness on one side of the body): 6 people, 85.71%
- Movement - Uncoordinated: 6 people, 85.71%
- Brain Stem Infarction (brainstem stroke): 6 people, 85.71%
- Diplopia (double vision): 6 people, 85.71%
- Dizziness: 6 people, 85.71%
- Dyskinesia (abnormality or impairment of voluntary movement): 6 people, 85.71%
- Facial Paresis (weakness in facial muscle movement): 6 people, 85.71%
- Basilar Artery Thrombosis (blood clot inside a basilar artery): 6 people, 85.71%
- Ophthalmoplegia (a paralysis or weakness of one or more of the muscles that control eye movement): 6 people, 85.71%
- Paresis Cranial Nerve (condition of muscular weakness due to cranial nerve): 6 people, 85.71%
Common conditions people have *:
- Platelet Disorder: 6 people, 85.71%
- High Blood Pressure: 6 people, 85.71%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 85.71%
- Retinal Oedema (swelling of retina): 1 person, 14.29%
- Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 1 person, 14.29%
- Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 1 person, 14.29%
- Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 14.29%
- Diabetic Eye Disease: 1 person, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Clopidogrel and have Macular ischaemia?Check whether Macular ischaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
- Saleh M, Bourcier T, Noel G, Speeg-Schatz C, Gaucher D, "Bilateral macular ischemia and severe visual loss following trastuzumab therapy", Acta Oncologica, 2011 Apr .
How severe was Macular ischaemia and when was it recovered:
Expand to all the drugs that have ingredients of clopidogrel:
Alternative drugs to, pros and cons of Clopidogrel:
- Clopidogrel (79,598 reports)
Common Clopidogrel side effects:
Browse all side effects of Clopidogrel:a b c d e f g h i j k l m n o p q r s t u v w x y z
Macular ischaemia treatments and more:
- Macular ischaemia (139 reports)
COVID vaccines that are related to Macular ischaemia:
- Macular ischaemia in Moderna COVID Vaccine
- Macular ischaemia in Pfizer BioNTech Covid Vaccine
- Macular ischaemia in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Macular ischaemia:
- Macular ischaemia (173 drugs)
All the conditions that are associated with Macular ischaemia:
- Macular ischaemia (77 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on clopidogrel (the active ingredients of Clopidogrel) and Clopidogrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Peridex and Pupillary Reflex Impaired - 4 seconds ago
- Cassia Senna and Anaphylaxis - 10 seconds ago
- Flagyl and Thalomid drug interaction - 24 seconds ago
- Coumadin and Creatinine Renal Clearance Decreased - 28 seconds ago
- Aromasin and Astigmatism - 36 seconds ago
- Clonazepam and Skin Disorder - 44 seconds ago
- Amiodarone Hydrochloride and Calquence drug interaction - 53 seconds ago
- Oxaliplatin and Nabumetone drug interaction - 57 seconds ago
- Lupron Depot and Ejaculation Failure - a minute ago
- Remicade and Bartholin'S Cyst - a minute ago